[Artificial intelligence-assisted diagnostics in the pathology of internal and oncological diseases].

IF 0.6
Innere Medizin (Heidelberg, Germany) Pub Date : 2026-06-01 Epub Date: 2026-04-29 DOI:10.1007/s00108-026-02120-6
Vincenzo Mitchell Barroso, Alexander Quaas, Reinhard Büttner, Yuri Tolkach
{"title":"[Artificial intelligence-assisted diagnostics in the pathology of internal and oncological diseases].","authors":"Vincenzo Mitchell Barroso, Alexander Quaas, Reinhard Büttner, Yuri Tolkach","doi":"10.1007/s00108-026-02120-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) is increasingly being implemented in digital pathology to support the tissue classification, cell detection, biomarker quantification, the grading and prediction of clinically relevant molecular alterations.</p><p><strong>Objective: </strong>Current applications of AI in the pathology of internal and oncological diseases are summarized with a focus on the most important algorithm approaches, representative cases of diagnostic applications and current limits of clinical implementation.</p><p><strong>Material and methods: </strong>This narrative overview of the most recent advances describes the essential model forms, including tissue segmentation systems, algorithms for recognition of individual cells, unsupervised learning and foundation models, tools for the evaluation of immunohistochemistry and multimodal or language-based applications. Representative studies on renal, liver, pulmonary, gastrointestinal, hematological and thyroid gland pathologies are discussed.</p><p><strong>Results: </strong>In many situations AI improves the reproducibility, objectiveness and efficiency. Some systems achieve an accuracy that is comparable to that of experts. Most AI tools are still in the validation stage and only a few have been transferred to routine clinical use.</p><p><strong>Discussion: </strong>Artificial intelligence could further optimize the diagnostic and predictive histopathology. Their role remains assistive. A broad implementation is limited due to various hurdles and bottlenecks. The future progress depends on prospective validation and the integration into routine digital workflows.</p>","PeriodicalId":73385,"journal":{"name":"Innere Medizin (Heidelberg, Germany)","volume":" ","pages":"609-618"},"PeriodicalIF":0.6000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innere Medizin (Heidelberg, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00108-026-02120-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Artificial intelligence (AI) is increasingly being implemented in digital pathology to support the tissue classification, cell detection, biomarker quantification, the grading and prediction of clinically relevant molecular alterations.

Objective: Current applications of AI in the pathology of internal and oncological diseases are summarized with a focus on the most important algorithm approaches, representative cases of diagnostic applications and current limits of clinical implementation.

Material and methods: This narrative overview of the most recent advances describes the essential model forms, including tissue segmentation systems, algorithms for recognition of individual cells, unsupervised learning and foundation models, tools for the evaluation of immunohistochemistry and multimodal or language-based applications. Representative studies on renal, liver, pulmonary, gastrointestinal, hematological and thyroid gland pathologies are discussed.

Results: In many situations AI improves the reproducibility, objectiveness and efficiency. Some systems achieve an accuracy that is comparable to that of experts. Most AI tools are still in the validation stage and only a few have been transferred to routine clinical use.

Discussion: Artificial intelligence could further optimize the diagnostic and predictive histopathology. Their role remains assistive. A broad implementation is limited due to various hurdles and bottlenecks. The future progress depends on prospective validation and the integration into routine digital workflows.

[人工智能在内科和肿瘤疾病病理学中的辅助诊断]。
背景:人工智能(AI)越来越多地应用于数字病理学,以支持组织分类、细胞检测、生物标志物量化、临床相关分子改变的分级和预测。目的:总结人工智能在内科和肿瘤学疾病病理学中的应用现状,重点介绍最重要的算法方法、诊断应用的代表性案例以及目前临床应用的局限性。材料和方法:这篇对最新进展的叙述性概述描述了基本的模型形式,包括组织分割系统、单个细胞识别算法、无监督学习和基础模型、免疫组织化学评估工具和多模态或基于语言的应用。讨论了肾、肝、肺、胃肠、血液学和甲状腺病理的代表性研究。结果:人工智能在许多情况下提高了再现性、客观性和效率。一些系统达到了与专家相当的精度。大多数人工智能工具仍处于验证阶段,只有少数已转移到常规临床应用。讨论:人工智能可以进一步优化组织病理学的诊断和预测。他们的作用仍然是协助。由于各种障碍和瓶颈,广泛的实施受到限制。未来的进展取决于前瞻性的验证和集成到日常的数字工作流程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书